Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.

AusPAR: Trastuzumab emtansine

Australian Public Assessment Report

AusPAR

AusPAR: Trastuzumab emtansine [PDF, 867.37 KB]

AusPAR: Trastuzumab emtansine [Word, 1 MB]

Attachment: Product information: Trastuzumab emtansine [PDF, 392.66 KB]

Attachment: Product information: Trastuzumab emtansine [Word, 260.29 KB]

Attachment: Extract from the Clinical Evaluation Report: Trastuzumab emtansine [PDF, 2.71 MB]

Attachment: Extract from the Clinical Evaluation Report: Trastuzumab emtansine [Word, 4.06 MB]

Device/Product Name

Kadcyla

Active ingredients

Trastuzumab emtansine

AusPAR Date

17 March 2014

Published

20 November 2014

Submission Number

PM-2012-02734-3-4

Submission Type

New chemical entity

Decision

Approved